Robert A. Schwartz

Schwartz joined the Trump administration as a member of the Presidential Advisory Council on HIV/AIDS in 2019.

Schwartz is also in his second term as President of the World Health Academy, serving from 2011 to 2012 and 2014 to present, and has been active on National Institutes of Health study sections since 2004. Schwartz has served as Faculty President of the Rutgers New Jersey Medical School in 1993 and 1995 and as Chairman of its Committee on Appointments and Promotions twice.

He has been involved in many campus activities, including as Sigma Xi Scientific Research Society chapter president and Alpha Omega Alpha National Honor Society chapter councilor. He received the Faculty of the Year Award at the Rutgers New Jersey Medical School in 2002 and has been chosen as Top Doctor multiple times by New York Magazine, Inside Jersey, and Castle-Conolly Guide to Best Physicians. A two-time past president of the Dermatology Section of the New York Academy of Medicine, he has been elected to a third five-year term on the Board of Directors of the International Society of Dermatology.

In 1984, Schwartz married Camila Krysicka, a dermatologist and academic. Their son Edmund Janniger was an advisor to Polish Defence Minister Antoni Macierewicz for a short period of time in 2015.

Schwartz advanced in academia, from the University of Arizona and the University of California, San Francisco to the Rutgers New Jersey Medical School, where in 1983 he became the first permanent head of dermatology, establishing a dermatology residency program in 1984. He is Professor and Dead of dermatology, Professor of Medicine, Professor of Pediatrics, and Professor of Preventive Medicine and Community Health at the Rutgers New Jersey Medical School. He is a Visiting Professor and Scholar of Public Affairs and Administration at the Rutgers School of Public Affairs and Administration. In 2014 Schwartz began serving on the Rutgers University Board of Trustees.

In 1981 Schwartz led one of the three groups that first described AIDS-associated Kaposi sarcoma (KS-AIDS). In 1978 he first described florid cutaneous papillomatosis. Schwartz is credited with the clinical description of new subtypes of Kaposi's sarcoma: telangiectatic Kaposi's sarcoma, keloidal Kaposi's sarcoma and ecchymotic Kaposi’s sarcoma. In 1981 he first described acral acanthotic anomaly (acral acanthosis nigricans). In 1980 Edmund Klein, Schwartz and associates published in Cancer one of the first effective treatments of Kaposi’s sarcoma, a type of cancer that became more frequent as the AIDS epidemic unfolded.

Schwartz has authored several books, most recently Skin Cancer: Recognition and Management, a leading book on cutaneous oncology currently in its second edition. He has written or edited 10 monographs, and is the author of over 250 book chapters, 500 articles, and 200 other publications. Many of these are in the area of dermatologic oncology, where he has had a special interest in epidermal tumors, paraneoplastic syndromes, and Kaposi’s sarcoma. He has published more than 50 full articles on Kaposi’s sarcoma since 1978, including one of the first three reports of KS-AIDS in 1981. He was the first to describe many Kaposi's sarcoma morphologic variants. In 1978 he first described florid cutaneous papillomatosis. In 1981 he discovered and described acral acanthosis nigricans. In 1994 he devised the commonly-accepted classification for acanthosis nigricans.

He earned a Bachelor of Arts in political science at the University of California, Berkeley in 1969, a Master of Public Health at the University of California, Berkeley School of Public Health in 1970, and a Doctor of Medicine at the New York Medical College in 1974, from which he graduated at the top of his class as a member of the Alpha Omega Alpha Honor Medical Society. He trained in dermatology at the University of Cincinnati and at Roswell Park Comprehensive Cancer Center. He advanced in academia, from the University of Arizona and the University of California, San Francisco, to the Rutgers New Jersey Medical School, where in 1983 he became the first permanent head of dermatology, establishing a dermatology residency program in 1984.

Robert Allen Schwartz FRCP Edin (born June 30, 1947) is an American physician, biomedical researcher, university professor, and government official. He is Professor and Head of Dermatology, Professor of Medicine, Professor of Pediatrics, and Professor of Preventive Medicine and Community Health at the Rutgers New Jersey Medical School, Visiting Professor and Scholar of Public Affairs and Administration at the Rutgers School of Public Affairs and Administration, and serves on the Rutgers University Board of Trustees. He has made seminal contributions to medicine, including the discovery of AIDS-associated Kaposi sarcoma (KS-AIDS) and Schwartz–Burgess syndrome. In 2019 Schwartz joined the Trump administration as a member of the Presidential Advisory Council on HIV/AIDS.

Robert Allen Schwartz was born on June 30, 1947, in Oakland, California. He spent his four undergraduate years at the University of California, Berkeley, graduating with a Bachelor of Arts in political science in 1969. He remained there to earn a Master of Public Health degree in 1970 from the University of California, Berkeley School of Public Health. He then matriculated into the New York Medical College in Manhattan, from which he graduated as a member of the Alpha Omega Alpha Honor Medical Society in 1974. He trained in dermatology at the University of Cincinnati College of Medicine and at Roswell Park Comprehensive Cancer Center. He later completed a fellowship in dermatopathology. Schwartz is board certified in dermatology and in diagnostic and laboratory immunology.